Oncogenic Ras differentially regulates metabolism and anoikis in extracellular matrix-detached cells

Area of Science:

• Oncology
• Cell Biology
• Molecular Signaling

Background:

• Cancer metastasis requires cells to survive extracellular matrix (ECM) detachment and anoikis (cell death).
• Metabolic defects arise from detachment, compromising cancer cell survival during metastasis.
• The specific signals cancer cells use to survive detachment are not fully understood.

Purpose of the Study:

• To investigate how oncogenic Ras facilitates cancer cell survival during metastasis.
• To identify the distinct effector pathways regulated by Ras for metabolism and anoikis.
• To elucidate the role of phosphatidylinositol (3)-kinase signaling and its downstream effectors in anoikis resistance.

Main Methods:

• Utilized cancer cell models to study survival mechanisms during ECM detachment.
• Investigated oncogenic Ras signaling pathways, including phosphatidylinositol (3)-kinase (PI3K) signaling.
• Analyzed the roles of serum and glucocorticoid-regulated kinase-1 (SGK-1), Akt, and PHLPP1 (PH Domain and Leucine-Rich Repeat Protein Phosphatase 1) in anoikis and metabolism.
• Examined the regulation of p38 MAPK (mitogen-activated protein kinase) signaling.

Main Results:

• Oncogenic Ras promotes survival of ECM-detached cancer cells via distinct pathways.
• Ras-mediated PI3K signaling is crucial for correcting metabolic deficits, with SGK-1 being the key effector, not Akt.
• Oncogenic Ras inhibits anoikis by decreasing PHLPP1 expression, which normally activates p38 MAPK.

Conclusions:

• A novel paradigm where oncogene signaling promotes survival of detached cancer cells through divergent downstream effectors.
• SGK-1 is identified as a critical mediator of Ras-driven metabolic adaptation during metastasis.
• PHLPP1 downregulation by Ras is a key mechanism for blocking anoikis and promoting cancer cell survival.